Skip to content

The COVID-19 Mobile Health Study (CMHS)

The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04275947
Acronym
CMHS
Enrollment
450
Registered
2020-02-19
Start date
2020-02-14
Completion date
2020-05-31
Last updated
2020-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on the clinical guidelines, clinical experience, and statistic training model. We will achieve secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training cohort and 300 cases in the validation cohort.

Interventions

OTHERnCapp, a cell phone-based auto-diagnosis system

Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19

Sponsors

Shanghai Respiratory Research Institution
CollaboratorUNKNOWN
Chinese Alliance Against Lung Cancer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* High risk of COVID-19 * RT-PCR test result of SAR2-CoV-19

Exclusion criteria

* Not available for RT-PCR test result of SAR2-CoV-19

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of nCapp COVID-19 risk diagnostic model1 daySensitivity, specificity and area under the ROC curve of nCapp model

Countries

China

Contacts

Primary ContactChunxue Bai
bai.chunxue@zs-hospital.sh.cn+8618621170011‬
Backup ContactDawei Yang
yang.dawei@zs-hospital.sh.cn+8613564703813

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026